![Matthias Hebben](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthias Hebben
Technik-/Wissenschafts-/F&E-Leiter bei
LOGICBIO THERAPEUTICS, INC.
Profil
Matthias Hebben is currently the Vice President & Head-Technology Development at LogicBio Therapeutics, Inc. Prior to this, he worked as the Director-AAV Technology & CMC Development at Genethon from 2013 to 2019 and as the Director-R&D Virology at Valneva SE from 2008 to 2013.
Hebben received his undergraduate degree from the University of Strasbourg and his doctorate from the University of Nice Sophia Antipolis.
He also received an undergraduate degree from Louis Pasteur University.
Aktive Positionen von Matthias Hebben
| Unternehmen | Position | Beginn |
|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2019 |
Ehemalige bekannte Positionen von Matthias Hebben
| Unternehmen | Position | Ende |
|---|---|---|
Genethon
 Genethon BiotechnologyHealth Technology Develops gene therapy products for rare diseases | Corporate Officer/Principal | 01.02.2019 |
| VALNEVA SE | Corporate Officer/Principal | 01.01.2013 |
Ausbildung von Matthias Hebben
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
17
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
University of Strasbourg
 University of Strasbourg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Nice Sophia Antipolis
 University of Nice Sophia Antipolis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genethon
Genethon BiotechnologyHealth Technology Develops gene therapy products for rare diseases | Health Technology |
Valneva SE
 Valneva SE BiotechnologyHealth Technology Develops and commercializes of prophylactic vaccines for infectious diseases | Health Technology |
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines and therapies for bone metabolism, cardiology, neurology and rare diseases | Health Technology |
Louis Pasteur University
 Louis Pasteur University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
